Click Here to return To Results

 

Oral Acyclovir Suppression and Neurodevelopment after Neonatal Herpes NEJM 365:1284-1292,1338, Kimberlin, D.W.,et al, 2011 See this aricle in Pubmed Article Abstract Infants surviving neonatal HSV disease with CNS involvement had improved neurodevelopmental outcomes when they received suppressive therapy with oral acyclovir for 6 months.

Related Tags

(click to filter results - removes previous filter) acyclovir antiviral agents developmental disability developmental evaluation herpes simplex encephalitis herpes simplex encephalitis,infancy and childhood herpes simplex virus herpes simplex virus infection,newborn prognosis term infant treatment of neurologic disorder viral infection,CNS

Click Here to return To Results